aTyr Pharma, Inc. (LSX:A2PM86) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kathryn Falberg Other companies: Nuvation Bio Inc. (Board of Directors · Since at least Feb 10, 2021); Arcus Biosciences, Inc. (Board Member · Since at least Mar 14, 2018); The Trade Desk, Inc. (Director · Since at least Sep 20, 2016); UroGen Pharma Ltd. (Director · Jan 1, 2019 – Jun 7, 2021 · Past); Tricida Inc (Director · Jun 27, 2018 – Jun 15, 2022 · Past); Sio Gene Therapies Inc (Director · Apr 7, 2017 – May 15, 2017 · Past); BioMarin Pharmaceutical Inc. (Director · Jul 15, 2016 – Jul 15, 2016 · Past); Aimmune Therapeutics Inc (Director · Aug 5, 2015 – Oct 10, 2020 · Past); Medivation Inc (Director · Jan 31, 2013 – Sep 28, 2016 · Past); Jazz Pharmaceuticals plc (EVP and CFO · Dec 1, 2009 – Mar 5, 2014 · Past); Novelion Therapeutics Inc (Director · Mar 25, 2009 – May 26, 2011 · Past); Oruka Therapeutics, Inc. (CFO and COO · Feb 23, 2009 – Jun 25, 2009 · Past); Halozyme Therapeutics, Inc. (Director · May 15, 2007 – May 4, 2016 · Past) | Director · May 6, 2015 – May 24, 2016 · Past |
| Amir Nashat Other companies: CAMP4 Therapeutics Corporation (Director · Since at least Oct 10, 2024); Metacrine Inc (Director · Sep 15, 2020 – May 18, 2022 · Past); Morphic Holding Inc (Director · Jun 26, 2019 – Aug 16, 2024 · Past); Scholar Rock Holding Corporation (Director · May 23, 2018 – May 9, 2024 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 1, 2022 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 14, 2019 · Past); Fate Therapeutics, Inc. (Director · Sep 30, 2013 – Jul 31, 2019 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 9, 2015 · Past); Receptos Inc (Director · May 8, 2013 – Jun 3, 2014 · Past) | Director · May 6, 2015 – May 15, 2018 · Past |
| James C Blair Other companies: Clovis Oncology Inc (Director · Nov 15, 2011 – Jun 10, 2021 · Past); Zogenix Inc (Director · Nov 22, 2010 – May 21, 2014 · Past); Cadence Pharmaceuticals Inc (Director · Oct 24, 2006 – Mar 19, 2014 · Past); Volcano Corp (Director · Jun 14, 2006 – Apr 24, 2008 · Past); Paratek Pharmaceuticals Inc (Director · May 9, 2006 – Jun 6, 2007 · Past); Pharmion Corp (Director · May 1, 2006 – Mar 7, 2008 · Past); NuVasive Inc (Director · Mar 3, 2006 – May 24, 2007 · Past) | Director · May 6, 2015 – May 8, 2019 · Past |
| Jeffrey S. Hatfield Other companies: Vir Biotechnology, Inc. (Chair of the Board · Since at least Dec 9, 2020); Larimar Therapeutics, Inc. (Chief Executive Officer, Director · Oct 9, 2017 – Jan 22, 2019 · Past); Viridian Therapeutics, Inc. (Director · Aug 10, 2017 – Feb 4, 2021 · Past); InVivo Therapeutics Holdings Corp (Director · Nov 1, 2016 – Jan 19, 2018 · Past); Vitae Pharmaceuticals Inc (Chief Executive Officer, Director · Sep 24, 2014 – Oct 24, 2016 · Past); Ambit Biosciences Corp (Director · Jun 2, 2014 – Nov 10, 2014 · Past) | Director · Apr 3, 2017 – May 6, 2020 · Past |
| Mark Alan Goldberg Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past) | Director · May 6, 2015 – May 9, 2017 · Past |
| John K Clarke Other companies: Verastem, Inc. (Director · Jan 26, 2012 – Jun 12, 2013 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – May 29, 2007 · Past); Momenta Pharmaceuticals Inc (Director · Jun 15, 2006 – Jun 10, 2015 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2006 – Jun 20, 2018 · Past); Visicu Inc (Director · Apr 4, 2006 – Feb 20, 2008 · Past) | Director · May 6, 2015 – May 22, 2024 · Past |
| Paul Schimmel Other companies: Alnylam Pharmaceuticals, Inc. (Co-founder and member of the Board of Directors · Since at least Jan 31, 2006); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – Nov 30, 2007 · Past); Repligen Corporation (Director · Aug 11, 2006 – Jun 14, 2007 · Past); Alkermes plc (Director · Mar 2, 2006 – Jun 15, 2007 · Past) | Director · Since at least May 6, 2015 |
| Timothy P. Coughlin Other companies: Vir Biotechnology, Inc. (Director · Since Jun 9, 2026); ADC Therapeutics SA (Director · Since at least Jun 3, 2025); Travere Therapeutics, Inc. (Director · Since at least Mar 31, 2015); Fate Therapeutics, Inc. (Director · Sep 30, 2013 – Jun 7, 2024 · Past); Neurocrine Biosciences, Inc. (Chief Financial Officer · Sep 18, 2006 – Feb 6, 2017 · Past) | Chairman · Since at least Apr 7, 2017 |
| Jill Marie Broadfoot Other companies: Cue Biopharma, Inc. (Director · Since at least Jun 4, 2025); Talphera, Inc. (Director · Since at least Nov 20, 2021); Otonomy Inc (Director · Aug 18, 2021 – Jun 21, 2022 · Past); Vical Incorporated (Sr Vice President, CFO, Sec · Jan 7, 2011 – Apr 1, 2013 · Past) | Chief Financial Officer · Since at least Jul 30, 2018 |
| John Mendlein Other companies: Fate Therapeutics, Inc. (Director · Since at least Sep 30, 2013); Omega Therapeutics Inc (Director · Jul 29, 2021 – Jun 20, 2024 · Past); Moderna, Inc. (See Remarks · Dec 7, 2018 – Dec 7, 2018 · Past); Editas Medicine, Inc. (Director · Feb 2, 2016 – Jun 15, 2017 · Past) | Director · May 6, 2015 – May 8, 2019 · Past |
| Jane A. Gross Other companies: BriaCell Therapeutics Corp (Director of the Board · Since at least Aug 1, 2022); Aptevo Therapeutics Inc. (SVP & Chief Scientific Officer · Sep 1, 2016 – Jan 29, 2021 · Past) | Director · Since at least Jun 28, 2019 |
| Svetlana Lucas Other companies: Scribe Therapeutics Inc. (Chief Business Officer · Since at least Mar 13, 2026); Jasper Therapeutics, Inc. (Board Member · Since at least Jun 18, 2024) | Director · Since at least Jun 28, 2019 |
| Eric Benevich Other companies: Neurocrine Biosciences, Inc. (Chief Commercial Officer · Since at least May 26, 2015) | Director · Since at least Dec 10, 2024 |
| John T Blake Other companies: Vivani Medical, Inc. (Chief Financial Officer · Mar 26, 2018 – Feb 19, 2020 · Past) | Senior Vice President, Finance · Oct 28, 2015 – Feb 6, 2018 · Past |
| Kelly Blackburn Other companies: CervoMed Inc. (Executive Vice President, Clinical Development · Since at least Aug 16, 2023) | VP, Clinical Affairs · May 6, 2015 – Mar 28, 2016 · Past |
| Andrew Cubitt | VP, Product Protection · May 6, 2015 – Sep 13, 2016 · Past |
| Ashlee Dunston | Investor Relations and Public Affairs · Since at least Oct 29, 2026 |
| Brandon Yaras | Chief Financial Officer · Since at least Aug 10, 2026 |
| Danielle Campbell | VP, Human Resources · Since at least Nov 5, 2026 |
| David John King | Chief Scientific Officer · Sep 21, 2016 – Feb 6, 2018 · Past |
| Fred Ramsdell | VP, Immunology · May 6, 2015 – Oct 1, 2015 · Past |
| Leslie Nangle | VP, Research · Since at least Oct 13, 2026 |
| Lisa Carey | VP, Clinical Operations · Since at least Sep 30, 2025 |
| Melissa A Ashlock | See Remarks · May 6, 2015 – Jan 27, 2016 · Past |
| Nancy Denyes | General Counsel · Since at least May 6, 2015 |
| Sanjay S. Shukla | President and CEO, Director · Since at least Mar 30, 2016 |
| Sanuj K Ravindran | Chief Business Officer · Jan 4, 2016 – Feb 7, 2017 · Past |
| Sara L. Zaknoen | Director · Since at least May 21, 2021 |
| Stan Blackburn | Acting Chief Financial Officer · May 6, 2015 – Jan 27, 2016 · Past |